These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 19716395)

  • 1. The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?
    Lee J; Boo JH; Ryu H
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1316-23. PubMed ID: 19716395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin as a mitochondrial protector in neurodegenerative diseases.
    Wongprayoon P; Govitrapong P
    Cell Mol Life Sci; 2017 Nov; 74(21):3999-4014. PubMed ID: 28791420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration as a consequence of failed mitochondrial maintenance.
    Karbowski M; Neutzner A
    Acta Neuropathol; 2012 Feb; 123(2):157-71. PubMed ID: 22143516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.
    Adhihetty PJ; Beal MF
    Neuromolecular Med; 2008; 10(4):275-90. PubMed ID: 19005780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective effects of intermittent fasting on brain aging and neurodegenerative diseases via regulating mitochondrial function.
    Zhao Y; Jia M; Chen W; Liu Z
    Free Radic Biol Med; 2022 Mar; 182():206-218. PubMed ID: 35218914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial medicine for aging and neurodegenerative diseases.
    Reddy PH
    Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial nuclear receptors and transcription factors: who's minding the cell?
    Lee J; Sharma S; Kim J; Ferrante RJ; Ryu H
    J Neurosci Res; 2008 Apr; 86(5):961-71. PubMed ID: 18041090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.
    Golpich M; Amini E; Mohamed Z; Azman Ali R; Mohamed Ibrahim N; Ahmadiani A
    CNS Neurosci Ther; 2017 Jan; 23(1):5-22. PubMed ID: 27873462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.
    Wilkins HM; Morris JK
    Curr Pharm Des; 2017; 23(5):731-752. PubMed ID: 28034353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria: a therapeutic target in neurodegeneration.
    Moreira PI; Zhu X; Wang X; Lee HG; Nunomura A; Petersen RB; Perry G; Smith MA
    Biochim Biophys Acta; 2010 Jan; 1802(1):212-20. PubMed ID: 19853657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders.
    Rahman MM; Tumpa MAA; Rahaman MS; Islam F; Sutradhar PR; Ahmed M; Alghamdi BS; Hafeez A; Alexiou A; Perveen A; Ashraf GM
    Curr Neuropharmacol; 2023; 21(5):1081-1099. PubMed ID: 36927428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
    Liddell JR
    Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases.
    Shang D; Huang M; Wang B; Yan X; Wu Z; Zhang X
    Curr Neuropharmacol; 2023; 21(3):578-598. PubMed ID: 35950246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species: stuck in the middle of neurodegeneration.
    Patten DA; Germain M; Kelly MA; Slack RS
    J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.